Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Envveno Medical Corp
(NQ:
NVNO
)
3.170
-0.030 (-0.94%)
Streaming Delayed Price
Updated: 2:09 PM EDT, Oct 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Envveno Medical Corp
< Previous
1
2
3
Next >
enVVeno Medical to Participate at the Virtual Investor Ask the CEO Conference
October 12, 2023
Via
ACCESSWIRE
enVVeno Medical Achieves Full Enrollment for VenoValve U.S. Pivotal Trial
October 06, 2023
Via
ACCESSWIRE
enVVeno Medical Announces New Expedited Development Plan for the enVVe(R) Transcatheter Based Replacement Venous Valve
October 06, 2023
Via
ACCESSWIRE
enVVeno Medical Announces Private Placement of $28 Million
October 06, 2023
Via
ACCESSWIRE
enVVeno Medical Reports Second Quarter 2023 Financial Results and Provides Corporate Update
July 31, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Wednesday's Intraday Session
July 19, 2023
Via
Benzinga
enVVeno Medical Reports First Quarter 2023 Financial Results and Provides Corporate Update
May 01, 2023
Via
ACCESSWIRE
enVVeno Medical to Present at Cowen's 43rd Annual Health Care Conference
February 08, 2023
Via
ACCESSWIRE
enVVeno Medical Successfully Passes Preliminary FDA Safety Review for the VenoValve U.S. Pivotal Study
November 07, 2022
Via
ACCESSWIRE
enVVeno Medical Reports Third Quarter 2022 Financial Results and Provides Corporate Update
October 27, 2022
Via
ACCESSWIRE
enVVeno Medical to Host Virtual KOL Event on July 18, 2023
July 14, 2023
Via
ACCESSWIRE
enVVeno Medical Provides Enrollment Update for Ongoing VenoValve(R) U.S. Pivotal Study and Announces Upcoming Investor and KOL Events
July 05, 2023
Via
ACCESSWIRE
enVVeno Medical Reports Fourth Quarter and Year-End 2022 Financial Results and Provides Corporate Update
March 02, 2023
Via
ACCESSWIRE
enVVeno Medical Promotes Dr. Hamed Alavi to Senior Vice President and Chief Technology Officer
January 18, 2023
Via
ACCESSWIRE
JTC Team to Host the Virtual Investor 2023 Companies to Watch Event on January 17th, 18th, and 19th
January 11, 2023
Via
ACCESSWIRE
enVVeno Medical to Host Conference Call and Webcast on September 21, 2022
September 19, 2022
Via
ACCESSWIRE
enVVeno Medical Reports Second Quarter 2022 Financial Results and Provides Corporate Update
August 03, 2022
Via
ACCESSWIRE
Positive 3-Year VenoValve(R) First-in-Human Data Presented at 49th Annual VEITH Symposium on Vascular and Endovascular Issues
November 17, 2022
Via
ACCESSWIRE
enVVeno Medical to Present at the Ladenburg Thalmann 2022 Healthcare Conference
September 22, 2022
Via
ACCESSWIRE
enVVeno Medical to Present at the H.C. Wainwright 24th Annual Global Investment Conference
September 12, 2022
Via
ACCESSWIRE
enVVeno Medical Appoints Kevin Belteau as Vice President of Clinical Operations
August 16, 2022
Via
ACCESSWIRE
enVVeno Medical Announces the Issuance of a New Unique Category III CPT Code Covering the Insertion of a Bioprosthetic Valve into the Femoral Vein
July 08, 2022
IRVINE, CA / ACCESSWIRE / July 8, 2022 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of venous disease, today...
From
enVVeno Medical Corporation
Via
AccessWire
enVVeno Medical Reports First Quarter 2022 Financial Results and Provides Corporate Update
May 02, 2022
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.
From
enVVeno Medical Corporation
Via
AccessWire
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 22, 2022
Gainers Vallon Pharmaceuticals (NASDAQ:VLON) shares moved upwards by 94.7% to $2.2 during Friday's pre-market session. The company's market cap stands at $14.9 million.
Via
Benzinga
enVVeno Medical Announces New U.S. VenoValve(R) Patent
April 11, 2022
- Expanding patent portfolio bolsters protection of the Company's lead product -The VenoValve is a potential first-in-class treatment for patients suffering from Chronic Venous Insufficiency (CVI) of...
From
enVVeno Medical Corporation
Via
AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
12 Health Care Stocks Moving In Monday's Intraday Session
March 28, 2022
Gainers TC BioPharm (Holdings) (NASDAQ:TCBP) shares rose 38.3% to $1.66 during Monday's regular session. The current volume of 3.5 million shares is 142.9% of TC...
Via
Benzinga
50 Biggest Movers From Yesterday
March 29, 2022
Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) shares gained 81.3% to close at $2.32 on Monday. Last week, AMC Entertainment Holdings purchased a major stake in...
Via
Benzinga
35 Stocks Moving In Monday's Mid-Day Session
March 28, 2022
Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) jumped 57.1% to $1.96 following reports regarding potential future investments from AMC CEO, Adam Aron....
Via
Benzinga
enVVeno Medical Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Corporate Update
March 28, 2022
- Ended the Year With $55 Million in Cash Expected To Fund Operations Through the End of 2024 Including Release of Topline Pivotal Trial Data - Nine (9) VenoValve Surgeries Successfully Completed and...
From
enVVeno Medical Corporation
Via
AccessWire
One-Year VenoValve(R) Data Published in Peer-Reviewed Journal, Vascular and Endovascular Surgery
March 09, 2022
- Previously announced promising results from the first-in-human study demonstrated sustained safety and effectiveness of the VenoValve at 1-year post-implantation - The VenoValve is currently being...
From
enVVeno Medical Corporation
Via
AccessWire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.